I recently came across (or to be exact, it came across me) an article in a journal suggesting that Alzheimer's may not be a brain disease at all, but possibly an autoimmune condition. This raises a deeply unsettling question: Have we been chasing the wrong target for the past 20 years? Could it be that the data that led us to beta-amyloid as the enemy was flawed — or worse, fabricated? But wait… article in the most respected Nature journal… How?
As scientists, we pride ourselves on our rationality, our rigorous pursuit of truth. But are we really immune to bias? Our human weakness lies in our susceptibility to fall into informational tunnels — where, rather than seeking new truths, we follow paths that reaffirm what we think we already know. This is the tunnel we've been walking when it comes to Alzheimer’s, and we may have followed it blindly.
For decades, billions have been spent developing treatments targeting amyloid plaques, while patients and families waited for cures that never came. And now, this new theory threatens to unravel the foundation of that entire approach. How many of us will stop and reconsider this path? How many will keep marching forward, convinced we’ve been on the right track?
This isn’t an isolated issue. Consider the case of nitrates. For 50 years, these compounds were branded as poisons, with thousands of studies, regulations, and norms set in place to limit their use. But nitrates are integral to the nitrogen cycle — the cycle of life itself. What we once thought of as toxic may actually be a key to extending life.
The parallels with Alzheimer’s research are hard to ignore. Are we mislabeling the core of the problem and, in doing so, condemning ourselves to decades of ineffective treatments? And in another 20, 30, or 50 years, will we be asking ourselves how much further we could have come if only we had stopped to question earlier?
Only time will tell. But as we move forward, I can’t help but wonder: Are we truly following the data — or simply the narrative we’ve built around it?
Comments